Mycophenolate

BreastfeedingGeriatricPediatric
  • TRADE NAMES: CellCept (Roche); Myfortic (Novartis)
  • INDICATIONS: Prophylaxis of organ rejection
  • SYNONYM: mycophenolate mofetil, mycophenolate sodium, mycophenolic acid
  • CLASS: Immunosuppressant
  • HALF-LIFE: 18 hours
EMBRYOFETAL TOXICITY, MALIGNANCIES AND SERIOUS INFECTIONS

See full prescribing information for complete boxed warning.

Our database has 111 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
HAIR
NAILS
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
ENDOCRINE/METABOLIC
GASTROINTESTINAL/HEPATIC
GENITOURINARY
HEMATOLOGIC
NEUROMUSCULAR/SKELETAL
OCULAR
RENAL
RESPIRATORY
OTHER


Visit Informa

Click on the DRUG REVIEW ARTICLE tab (above) to see a review of mycophenolate in the Taylor & Francis journal Expert Opinion on Drug Safety. (Note that non-subscribers to the journal will only be able to see an abstract of the article.)

Page last updated 03/18/2019

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top